Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | USP8 | P40818 | 1/20 | 0.31 |
| ▸ | USP7 | Q93009 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | PIM1 | P11309 | 1/20 | 0.31 |
| ▸ | CDC25A | P30304 | 1/20 | 0.31 |
| ▸ | CDC25B | P30305 | 1/20 | 0.31 |
| ▸ | AR | P10275 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3946811 | 0.95 | GPR84 (0.62) | GPR84TSHRCA1CA2USP8 | |
| Ammonia Solution, Strong SCHEMBL3949938 | 0.85 | GPR84 (0.53) | GPR84TSHRCA1CA2 | |
| SCHEMBL29624824 | 0.78 | GPR84 (0.50) | GPR84USP8USP7PIM1CDC25A | |
| SCHEMBL2781483 | 0.78 | GPR84 (0.50) | GPR84USP8USP7PIM1CDC25A | |
| SCHEMBL15122251 | 0.77 | GPR84 (0.49) | GPR84TSHRCA1CA2 | |
| SCHEMBL11486708 | 0.74 | GPR84 (0.50) | GPR84 | |
| SCHEMBL5677258 | 0.74 | GPR84 (0.50) | GPR84 | |
| SCHEMBL6371108 | 0.74 | GPR84 (0.50) | GPR84CA1CA2 | |
| SCHEMBL4922451 | 0.72 | MAPK1 (0.52) | GPR84TSHRUSP8USP7 | |
| SCHEMBL9347855 | 0.71 | GPR84 (0.38) | GPR84CDC25ACDC25B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108083963-B | Synthetic method of diarylethene | 中国工程物理研究院激光聚变研究中心 | 2020-08-28 | — | — | CN | disclosed |